Live Breaking News & Updates on Rosa Therapeutics|Page 7

Stay updated with breaking news from Rosa therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules

Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Monta Rosa Qu , Cory Tromblee , Monte Rosa , Andrew Funderburk , Exchange Commission On , Exchange Commission , Monte Rosa Therapeutics Inc , Rosa Therapeutics Announces , Registered Direct Offering , Market Under Nasdaq , Rosa Therapeutics , Monte Rosa Therapeutics , Engineered Elimination , Private Securities Litigation Reform Act , Annual Report ,

FY2023 EPS Estimates for Monte Rosa Therapeutics, Inc. Raised by Leerink Partnrs (NASDAQ:GLUE)

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) – Equities researchers at Leerink Partnrs raised their FY2023 EPS estimates for shares of Monte Rosa Therapeutics in a note issued to investors on Tuesday, October 17th. Leerink Partnrs analyst C. Liu now forecasts that the company will earn ($1.75) per share for the year, up from […] ....

Leerink Partnrs , Credit Suisse Group , Vanguard Group Inc , Blackrock Inc , Monte Rosa Therapeutics Inc , Citadel Advisors , Jpmorgan Chase Co , Monte Rosa Therapeutics , Free Report , Monte Rosa Therapeutic , Rosa Therapeutics , Get Free Report , Suisse Group , Point Capital Management , Monte Rosa Therapeutics Daily , Nasdaq Glue , Earnings Estimates ,